Hemophilia Federation of America is a national nonprofit organization that assists, educates, and advocates for the bleeding disorders community.
Note: The below is an edited version of an article originally published on BusinessWire. The original article can be read in their entirety here. The latest data from an ongoing Japanese Phase I/II study of Emicizumab were presented earlier this week at the World Federation of Hemophilia 2016 World Congress. Emicizumab (a product being developed by […]
Sign up for E-mails, Dateline Newsletter, and other ways to stay connected.